Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 10, 2021

SELL
$310.19 - $376.2 $366,334 - $444,292
-1,181 Closed
0 $0
Q2 2021

Aug 09, 2021

SELL
$262.71 - $351.17 $132,931 - $177,692
-506 Reduced 29.99%
1,181 $368,000
Q1 2021

May 13, 2021

SELL
$285.92 - $355.13 $152,395 - $189,284
-533 Reduced 24.01%
1,687 $538,000
Q4 2020

Feb 08, 2021

SELL
$251.88 - $324.2 $498,722 - $641,916
-1,980 Reduced 47.14%
2,220 $720,000
Q3 2020

Oct 30, 2020

SELL
$255.22 - $317.0 $76,566 - $95,100
-300 Reduced 6.67%
4,200 $1.16 Million
Q2 2020

Aug 05, 2020

BUY
$141.4 - $257.09 $636,300 - $1.16 Million
4,500 New
4,500 $1.09 Million
Q1 2019

May 08, 2019

SELL
$276.39 - $362.25 $1.3 Million - $1.7 Million
-4,700 Closed
0 $0
Q3 2018

Nov 02, 2018

BUY
$354.53 - $449.75 $1.67 Million - $2.11 Million
4,700 New
4,700 $2.11 Million

Others Institutions Holding ABMD

About ABIOMED INC


  • Ticker ABMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 45,460,900
  • Description
  • Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...
More about ABMD
Track This Portfolio

Track Bp PLC Portfolio

Follow Bp PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bp PLC, based on Form 13F filings with the SEC.

News

Stay updated on Bp PLC with notifications on news.